Believe it or not, Pfizer’s drug Viagra was originally designed to treat cardiovascular problems. Early on in clinical trials, men taking the drug became…
Biogen and Eisai’s monoclonal antibody drugs for Alzheimer’s — Aduhelm (now off the market) and Leqembi (fully approved by the FDA in 2023) —…
The internet is abuzz with claims that biomarker blood tests are the key to predicting dementia 15 years out. Indeed, up to now, the…
Scientists have known for years that unhealthy diets – particularly those that are high in fat and sugar – may cause detrimental changes to…
Alzheimer’s disease affects one in 10 people over the age of 65 and one in three over the age of 85, and its global…
This week Being Patient did an extensive series of reports on blood tests for Alzheimer’s, because beyond the headlines, there are a lot of…
Nothing is more exciting than when my favorite basketball team, the Toronto Raptors, announced that they were signing a star player that could help…
Dementia doesn’t just affect the brain of a patient. As clinical psychologist, educator, and author Dasha Kiper explores in her new book, the disease…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
An Alzheimer’s blood biomarker test can’t actually determine whether or not a person has Alzheimer’s disease — but it can help signal to doctors…
Alzheimer’s blood tests: a new frontier in neurodegenerative diagnostics, getting the world a big step closer to earlier, more accessible Alzheimer’s diagnosis. But it’s…
This month is Black History Month. Let’s talk about the impacts that history has on public health in the present: Alzheimer’s doesn’t discriminate, but…
The U.S. is in the midst of a racial reckoning. The COVID-19 pandemic, which took a particularly heavy toll on Black communities, turned a…
What causes Alzheimer’s disease and related forms of progressive dementia? Scientists still don’t know. One leading theory points to beta-amyloid protein — a biomarker…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Caribbean neuroscientist Indira Turney’s research is centered…